Phase II study of the anti-insulin-like growth factor type 1 receptor antibody CP-751,871 in combination with paclitaxel and carboplatin in previously untreated, locally advanced, or metastatic non-small-cell lung cancer
Journal of Clinical Oncology (2009) - Comment
pubmed: 19380445  doi: 10.1200/jco.2008.19.9331  issn: 1527-7755  issn: 0732-183x 

Daniel D. Karp, Luis G. Paz-Ares, Silvia Novello, Paul Haluska, Linda Garland, Felipe Cardenal, L. Johnetta Blakely, Peter D. Eisenberg, Corey J. Langer, George Blumenschein, Faye M. Johnson, Stephanie Green, Antonio Gualberto